January 02, 2026

Curative Treatment After First-Line Immunotherapy Improves Survival in HCC

Curative treatment—resection, transplantation, and/or local ablation—following first-line immunotherapy is infrequently received, but when it was utilized, it significantly improved overall survival o...

The ASCO Post

December 22, 2025

UICC’s World Cancer Declaration 2025–2035

The Union for International Cancer Control (UICC) published its World Cancer Declaration 2025–2035 framework on November 19, 2025.1 The declaration urges governments and policymakers to take decisive ...

The ASCO Post

December 22, 2025

Eliminating Barriers to Care for Patients With Intellectual and/or Developmental Disabilities

A recent large, retrospective study by Giblon et al has found that individuals with intellectual and/or developmental disabilities face an increased risk of developing cancer, higher symptom burden on...

The ASCO Post

December 22, 2025

Deb Schrag, MD, MPH, FASCO, Elected 2027–2028 ASCO President

Dr. Schrag, a gastrointestinal medical oncologist, is the George J. Bosl Chair of the Department of Medicine at Memorial Sloan Kettering Cancer Center and Professor of Medicine at Weill Cornell Medica...

The ASCO Post

December 19, 2025

SIO 2025: The Future of Integrative Oncology

Guest Editor’s Note: In October, the Society for Integrative Oncology (SIO) held its annual international conference in Boston. The theme was “The Future of Integrative Oncology,” with presentations a...

The ASCO Post

December 19, 2025

Gemcitabine Intravesical System Shows High Disease-Free Survival Rates in BCG-Unresponsive Papillary-Only NMIBC

Monotherapy with a gemcitabine intravesical system demonstrated high disease-free survival rates in patients with bacillus Calmette-Guérin-unresponsive papillary-only high-risk non–muscle-invasive bla...

The ASCO Post

December 18, 2025

How an Endowed Chair in Cord Blood Research Is Providing New Hope for Patients With High-Risk Leukemia

In 2016, Filippo Milano, MD, PhD, Associate Professor, Translational Science and Therapeutics Division, and Director of the Cord Blood Transplant Program at Fred Hutchinson Cancer Center in Seattle, p...

The ASCO Post

December 18, 2025

A Pioneer’s Approach to Rectal Spacers for Prostate Cancer Treatment

Marcio Fagundes, M.D., is emerging as a transformative voice in radiation oncology, pioneering the use of rectal spacers to shield the rectum from potential radiation damage during the treatment of prostate cancer.

Baptist Health South Florida

December 17, 2025

Transforming COPD Care: WashU Medicine Physicians at Barnes-Jewish Hospital Combine Expertise with Advanced Treatments

Chronic obstructive pulmonary disease (COPD) continues to be one of the leading causes of disability and death in the United States, yet it remains underdiagnosed and undertreated with treatment historically centered on smoking cessation and a series of inhalers.

Barnes-Jewish